Sanderling Ventures

About The Fund

Sanderling Ventures is among the oldest investment firms dedicated to building new biomedical companies, fostering growth and innovation since its foundation in 1979. They focus on early-stage financing and active management with a specialized investment interest in the fields of biotechnology, life sciences, therapeutics, and pharmaceuticals. Their portfolio extends to encompass drug delivery, medical devices and instrumentation, diagnostics, medical informatics, healthcare information technology, and health care services. With a hands-on approach, they collaborate closely with entrepreneurs to build significant companies, applying a unique combination of specialized investment focus along with active management and a long-term commitment. This strategic methodology aims to yield high rates of return for both the entrepreneurs they partner with and their investors. Their investments range from a minimum of $50,000 to a maximum of $1,000,000. With assets under management amassing to $900,000,000, Sanderling Ventures provides seed, startup, and early-stage funding while harnessing their extensive expertise in equity investments. Their specialties include small molecule therapeutics, biologics and vaccines, drug delivery, platform technologies, and medical devices. Sanderling Ventures believes that the greatest companies are best constructed through close working partnerships with founders, which is reflected in their active management ethos. They hold a prominent position by being one of the oldest players in the space of biomedical venture capital funding, underlining their longstanding commitment to the healthcare sector.